Boxer Capital Management’s G1 Therapeutics GTHX Stock Holding History
Bought
Maintained
Sold
Other funds holding GTHX
Boxer Capital Management's GTHX Position: Q2 2018 in Review
Boxer Capital Management sold out of G1 Therapeutics (GTHX) in Q2 2018, closing a stake of 660,000 shares — an estimated $24.5M sold.
Boxer Capital Management first reported a position in GTHX in Q2 2017 and held it in 4 quarters. The position peaked at $24.5M in Q1 2018. 95 funds tracked by Wall St. Rank hold GTHX as of Q2 2018.
- Boxer Capital Management reported no remaining G1 Therapeutics position as of Q2 2018 after selling out during the quarter.
- Boxer Capital Management sold 660,000 G1 Therapeutics shares in Q2 2018, an estimated $24.5M.
- Boxer Capital Management first reported a position in G1 Therapeutics in Q2 2017 and held it in 4 quarters.
- Boxer Capital Management's G1 Therapeutics position peaked at $24.5M in Q1 2018.
- 95 funds tracked by Wall St. Rank held G1 Therapeutics as of Q2 2018.
Based on Boxer Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.